相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients
Larry A. Harshyne et al.
NEURO-ONCOLOGY (2016)
Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models
Franziska Eckert et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
Scott Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune-priming of the Tumor Microenvironment by Radiotherapy Rationale for Combination With Immunotherapy to Improve Anticancer Efficacy
Vafa Shahabi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Why has active immunotherapy not worked in lung cancer?
A. Thomas et al.
ANNALS OF ONCOLOGY (2015)
Awakening the immune system with radiation: Optimal dose and fractionation
Saumil J. Gandhi et al.
CANCER LETTERS (2015)
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
Kobe Reynders et al.
CANCER TREATMENT REVIEWS (2015)
Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions
Alexander Filatenkov et al.
CLINICAL CANCER RESEARCH (2015)
Immunotherapy for non-small-cell lung cancer: the past 10 years
Johan Vansteenkiste et al.
FUTURE ONCOLOGY (2015)
Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospective Trials
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Chronic graft-versus-host-disease in CD34+-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease
Katja Sonntag et al.
JOURNAL OF AUTOIMMUNITY (2015)
Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries
Daniel M. Trifiletti et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
Michel M. van den Heuvel et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma
Sebastien Wieckowski et al.
LUNG CANCER (2015)
Prospects of immune checkpoint modulators in the treatment of glioblastoma
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model
Nicolle H. Rekers et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence
Ulrike Schick et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer
Feifei Teng et al.
TRANSLATIONAL RESEARCH (2015)
Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
Ida Silvestri et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
Francesca De Felice et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
Karin Schilbach et al.
ONCOIMMUNOLOGY (2015)
Melanoma: from incurable beast to a curable bet. The success of immunotherapy
Maria Libera Ascierto et al.
FRONTIERS IN ONCOLOGY (2015)
Immunotherapy of childhood Sarcomas
Stephen S. Roberts et al.
FRONTIERS IN ONCOLOGY (2015)
Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects
Catharina M. L. Zegers et al.
CLINICAL CANCER RESEARCH (2015)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
The mechanisms responsible for the radiosensitizing effects of sorafenib on colon cancer cells
Eun Ho Kim et al.
ONCOLOGY REPORTS (2014)
Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19-IL2 Results in Sustained Clinical and Systemic Immunologic Responses
Benjamin Weide et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
Irena Adkins et al.
ONCOIMMUNOLOGY (2014)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al.
ONCOIMMUNOLOGY (2014)
Human NK Cell Receptors/Markers: A Tool to Analyze NK Cell Development, Subsets and Function
Elisa Montaldo et al.
CYTOMETRY PART A (2013)
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis
Matthias Guckenberger et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin-Positive Metastatic Human Melanoma Xenografts
Michele Moschetta et al.
CANCER RESEARCH (2012)
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
Intratumoral hu14.18-IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention
Richard K. Yang et al.
JOURNAL OF IMMUNOLOGY (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Sandra Demaria et al.
FRONTIERS IN ONCOLOGY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Current and Potential Uses of Immunocytokines as Cancer Immunotherapy
Paul M. Sondel et al.
ANTIBODIES (2012)
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
Thomas K. Eigentler et al.
CLINICAL CANCER RESEARCH (2011)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Sid P. Kerkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Ole Audun Werner Haabeth et al.
NATURE COMMUNICATIONS (2011)
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Manfred Johannsen et al.
EUROPEAN JOURNAL OF CANCER (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor α subunit CD25
Sven Letourneau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions
Lorenzo Mortara et al.
INTERNATIONAL IMMUNOLOGY (2009)
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma
Antoni Ribas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis
Yao Dai et al.
CLINICAL CANCER RESEARCH (2008)
Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells
Margret Rave-Fraenk et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line
J Kjellström et al.
ACTA ONCOLOGICA (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors
MD Chiesa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
分享论文
